登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C18H36N4O11 · H2O4S
化学文摘社编号:
分子量:
582.58
EC Number:
246-933-9
UNSPSC Code:
51101500
MDL number:
grade
Biotechnology Performance Certified
technique(s)
cell culture | mammalian: suitable
impurities
endotoxin, tested
antibiotic activity spectrum
mycobacteria
mode of action
protein synthesis | interferes
storage temp.
2-8°C
SMILES string
OS(O)(=O)=O.NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
InChI
1S/C18H36N4O11.H2O4S/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17;1-5(2,3)4/h4-18,23-29H,1-3,19-22H2;(H2,1,2,3,4)/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-;/m1./s1
InChI key
OOYGSFOGFJDDHP-KMCOLRRFSA-N
正在寻找类似产品? 访问 产品对比指南
General description
Chemical structure: aminoglycoside
Application
在生物技术中用于抑制蛋白质合成。
Biochem/physiol Actions
作用机制:该产品通过与70S核糖体亚基结合,抑制易位并引起错误编码而起作用。
耐药机制:氨基糖苷类修饰酶(包括乙酰转移酶、磷酸转移酶、核苷酸转移酶)可以改变这种抗生素,阻止其与核糖体相互作用。
抗菌谱:硫酸卡那霉素对革兰氏阴性和革兰氏阳性菌以及支原体有效。
耐药机制:氨基糖苷类修饰酶(包括乙酰转移酶、磷酸转移酶、核苷酸转移酶)可以改变这种抗生素,阻止其与核糖体相互作用。
抗菌谱:硫酸卡那霉素对革兰氏阴性和革兰氏阳性菌以及支原体有效。
signalword
Danger
hcodes
Hazard Classifications
Repr. 1B
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 2
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
涉药品监管产品
此项目有
Mitsutaka Kitano et al.
Antimicrobial agents and chemotherapy, 58(8), 4795-4803 (2014-06-11)
Highly pathogenic avian influenza A (H5N1) viruses cause severe and often fatal disease in humans. We evaluated the efficacy of repeated intravenous dosing of the neuraminidase inhibitor peramivir against highly pathogenic avian influenza virus A/Vietnam/UT3040/2004 (H5N1) infection in cynomolgus macaques.
Atef Allam et al.
Journal of immunology (Baltimore, Md. : 1950), 193(2), 871-878 (2014-06-11)
The role of the TNF family member CD70 in adaptive T cell responses has been intensively studied, but its function in innate responses is still under investigation. In this study, we show that CD70 inhibits the early innate response to
Motoyasu Onishi et al.
Antiviral research, 117, 52-59 (2015-03-11)
Influenza virus infection increases susceptibility to bacterial infection and mortality in humans. Although the efficacy of approved intravenous peramivir, a neuraminidase (NA) inhibitor, against influenza virus infection has been reported, its efficacy against bacterial co-infection, which occurs during the period
Fakhri Jeddi et al.
Antimicrobial agents and chemotherapy, 58(8), 4866-4874 (2014-06-11)
Antimonials remain the first-line treatment for the various manifestations of leishmaniasis in most areas where the disease is endemic, and increasing cases of therapeutic failure associated with parasite resistance have been reported. In this study, we assessed the molecular status
Koki Iwata et al.
Biological & pharmaceutical bulletin, 37(9), 1510-1515 (2014-07-06)
Antigen-specific immunoglobulin A (IgA) may be useful for preventing infectious diseases through passive immunization on the mucosal surface. We previously established mouse IgA and IgG monoclonal antibodies (mAbs) specific for the binding subunit of Shiga toxin 1 (Stx1B). We also
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持